AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update Continuing to advance clinical active immunotherapy portfolio for precision prevention of neurodegenerative disea ...

Based on further interim results to be reported later in 2025, including pharmacodynamic and biomarker data, AC Immune may decide to initiate Part 2 of VacSYn, with the aim of establishing early proof ...

DÜSSELDORF, 30 April 2025 - The CLIQ Group will report and present its first quarter 2025 financial results and highlights on Thursday, 8 May 2025. The 1Q 2025 Financial Report and a slides deck to ...

April 29, 2025) - Mundoro Capital Inc. (TSXV: MUN) (OTCQB: MUNMF) ( ("Mundoro" or the "Company") announces the operating and financial results for the year ended December 31, 2024. The audited ...

Company affirms guidance and outlooks NEW ORLEANS, April 29, 2025 /PRNewswire/ -- Entergy Corporation (NYSE: ETR) reported first quarter 2025 earnings per share ...

FARGO — Two upcoming Alzheimer’s Association webinars will focus on communication and dementia. Alzheimer’s Association ...

Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today ...

Bankwell Financial Group, Inc. ( NASDAQ: BWFG) Q1 2025 Earnings Conference Call April 24, 2025 10:00 AM ET Courtney Sacchetti - Chief Financial Officer Chris Gruseke - Chief Executive Officer Matt ...

May 2025 is a month of transition, introspection, and rising career momentum for Leo natives. The Suns transit from the Ninth ...

Reimagining the power of investing. Connecting people for a better world. The products, services, information and/or materials contained within these web pages may not be available for residents of ...

DALLAS, April 16, 2025 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) has released its first quarter 2025 financial results. The 1Q 2025 financial results and shareholder letter are ...